Ligand validation:6PP3

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PP3_BTB_B_509	82%	66%	0.115	0.972	0.36	0.94	-	1	5	0	100%	1
6PP3_BTB_A_504	81%	58%	0.112	0.965	0.48	1.11	-	1	5	0	100%	1
6PP3_BTB_B_504	63%	82%	0.119	0.914	0.36	0.43	-	-	2	0	100%	1
6PP3_BTB_B_510	53%	49%	0.191	0.952	0.84	1.11	1	-	5	0	100%	1
6PP3_BTB_B_505	46%	75%	0.17	0.905	0.42	0.54	-	-	4	0	100%	1
6PP3_BTB_D_505	46%	59%	0.184	0.919	0.59	0.96	-	-	5	0	100%	1
6PP3_BTB_A_505	46%	72%	0.176	0.91	0.46	0.6	-	-	3	0	100%	1
6PP3_BTB_C_504	44%	79%	0.114	0.84	0.43	0.44	-	-	6	0	100%	1
6PP3_BTB_D_504	33%	85%	0.171	0.847	0.41	0.34	-	-	4	0	100%	1
6PP3_BTB_A_506	30%	83%	0.168	0.832	0.33	0.44	-	-	2	0	100%	1
6PP3_BTB_B_506	17%	82%	0.168	0.744	0.38	0.41	-	-	0	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9Q4X_BTB_A_504	100%	62%	0.027	0.995	0.56	0.88	-	-	6	0	100%	1
9Q58_BTB_A_504	100%	66%	0.029	0.995	0.43	0.88	-	-	2	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.